The authors reply.

Autor: Raffa JD; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA., Johnson AEW; Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, ON, Canada., O'Brien Z; Austin Health, Melbourne, VIC, Australia., Pollard TJ; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA., Mark RG; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA.; Beth Israel Deaconess Medical Center, Boston, MA., Celi LA; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA.; Beth Israel Deaconess Medical Center, Boston, MA., Pilcher D; Department of Intensive Care and Hyperbaric Medicine, Alfred Hospital, Melbourne, VIC, Australia.; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, VIC, Australia.; Centre for Outcome and Resource Evaluation, Australian and New Zealand Intensive Care Society, Melbourne, VIC, Australia., Badawi O; Medical Device Innovation Consortium, Arlington, VA.
Jazyk: angličtina
Zdroj: Critical care medicine [Crit Care Med] 2022 Nov 01; Vol. 50 (11), pp. e801-e802. Date of Electronic Publication: 2022 Oct 13.
DOI: 10.1097/CCM.0000000000005648
Abstrakt: Competing Interests: Dr. Raffa’s institution received funding from Philips Healthcare. Drs. Raffa, Pollard, Mark, and Celi received support for article research from the National Institutes of Health. Dr. Mark received funding from Philips Research. Dr. Badawi received funding from Ceiba Health and Philips Healthcare. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Databáze: MEDLINE